Gainers
- Oyster Point Pharma OYST shares moved upwards by 38.7% to $11.59 during Monday's regular session. Oyster Point Pharma's stock is trading at a volume of 6.2 million shares as of 12:32 EST. This is 6106.9% of its average full-day volume over the last 100 days. The company's market cap stands at $310.8 million.
- Monopar Therapeutics MNPR stock increased by 28.75% to $3.85. Trading volume for Monopar Therapeutics's stock is 107.7K as of 12:32 EST. This is 913.3% of its average full-day volume over the last 100 days. The company's market cap stands at $48.9 million.
- Eagle Pharmaceuticals EGRX stock moved upwards by 23.53% to $38.98. As of 12:32 EST, this security is trading at a volume of 90.0K shares, making up 50.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $507.2 million. The company's, Q3 earnings came out today.
- Certara CERT stock moved upwards by 18.45% to $12.62. Certara's stock is trading at a volume of 1.3 million shares as of 12:32 EST. This is 159.3% of its average full-day volume over the last 100 days. The company's market cap stands at $2.0 billion. The company's, Q3 earnings came out today.
- Aptinyx APTX shares moved upwards by 17.69% to $0.31. The current volume of 284.0K shares is 67.9% of Aptinyx's average full-day volume over the last 100 days (last updated at 12:32 EST). The market value of their outstanding shares is at $20.9 million.
- DermTech DMTK stock increased by 17.59% to $1.95. Trading volume for this security as of 12:32 EST is 1.3 million, which is 279.2% of its average full-day volume over the last 100 days. The company's market cap stands at $58.6 million. As per the news, the Q3 earnings report came out 2 days ago.
Losers
- Bio-Path Holdings BPTH stock declined by 40.0% to $1.71 during Monday's regular session. Bio-Path Holdings's stock is trading at a volume of 153.1K shares as of 12:32 EST. This is 886.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $12.2 million.
- Checkpoint Therapeutics CKPT stock fell 29.15% to $0.64. Trading volume for this security as of 12:32 EST is 1.7 million, which is 654.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $59.1 million.
- Verve Therapeutics VERV stock declined by 25.38% to $23.35. As of 12:32 EST, Verve Therapeutics's stock is trading at a volume of 3.1 million, which is 331.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.3 billion. As per the news, the Q3 earnings report came out today.
- Biophytis BPTS stock decreased by 16.6% to $0.51. The market value of their outstanding shares is at $10.4 million.
- NextCure NXTC shares fell 15.8% to $1.67. As of 12:32 EST, NextCure's stock is trading at a volume of 288.0K, which is 255.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $46.2 million. As per the news, the Q3 earnings report came out 2 days ago.
- Virax Biolabs Group VRAX stock fell 14.91% to $1.41. As of 12:32 EST, Virax Biolabs Group's stock is trading at a volume of 301.4K, which is 11.0% of its average full-day volume over the last 100 days. The company's market cap stands at $16.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in